The prognostic value of ECG and right heart catheterization parameters in heart failure patients with reduced ejection fraction

心电图和右心导管检查参数对射血分数降低的心力衰竭患者的预后价值

阅读:1

Abstract

INTRODUCTION: Electrocardiographic (ECG) markers such as the Tpeak-Tend interval (Tpe), QRS interval, and fragmented QRS (fQRS) are increasingly recognized as predictors of clinical outcomes in heart failure patients with reduced ejection fraction (HFrEF). However, the association of these ECG markers with invasive hemodynamic parameters remains underexplored. AIM: The primary objective of this study is to assess the prognostic value of ECG parameters in patients with HFrEF. The secondary aim is to investigate the relationship between ECG markers (Tpe, QRS interval, and fQRS) and invasive hemodynamic parameters in these patients. MATERIAL AND METHODS: A total of 325 patients with HFrEF who underwent right heart catheterization between January 2007 and January 2017 were included in this cross-sectional study. The primary end-points were defined as all-cause mortality and composite end-point (CEP) (recently undergone heart transplant surgery, mechanical circulatory support, and all-cause mortality). RESULTS: During a median follow-up of 28.1 months, all-cause mortality was observed in 138 patients. Patients with CEP (n = 156) had longer QRS, Tpe intervals, and a greater number of fQRS complexes (p < 0.05). Prolonged QRS and Tpe intervals showed significant correlations with elevated pulmonary artery pressures and reduced cardiac output (p < 0.05). Every one ms increase in Tpe and QRS intervals was associated with a 3% and 5% increase in CEP, respectively. Tpe and QRS intervals were found to be independent predictors of CEP and all-cause mortality in patients with HFrEF. CONCLUSIONS: Tpe and QRS intervals provide valuable information regarding the hemodynamic status and prognosis in patients with HFrEF. These simple ECG parameters may serve as noninvasive tools for risk stratification and aid in clinical decision-making in this high-risk population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。